Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Fonseca, Kari R.
2158  Ergebnisse:
Personensuche X
?
1

Discovery of the Potent and Selective MC4R Antagonist PF-07..:

Garnsey, Michelle R. ; Smith, Aaron C. ; Polivkova, Jana...
Journal of Medicinal Chemistry.  66 (2023)  5 - p. 3195-3211 , 2023
Link: https://doi.org/10.1021/..
 
?
2

Effect of a Ketohexokinase Inhibitor (PF‐06835919) on In Vi..:

Tess, David A. ; Kimoto, Emi ; King‐Ahmad, Amanda...
Clinical Pharmacology & Therapeutics.  112 (2022)  3 - p. 605-614 , 2022
Link: https://doi.org/10.1002/..
 
?
3

Target occupancy study and whole-body dosimetry with a MAGL..:

Arakawa, Ryosuke ; Takano, Akihiro ; Nag, Sangram...
EJNMMI Research.  12 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
4

The Effects of a Novel Non-catechol Dopamine Partial Agonis..:

Moore, Tara L. ; Young, Damon A. ; Killiany, Ronald J....
Frontiers in Aging Neuroscience.  13 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
5

D1 Agonist Improved Movement of Parkinsonian Nonhuman Prima..:

Young, Damon ; Popiolek, Michael ; Trapa, Patrick...
ACS Chemical Neuroscience.  11 (2020)  4 - p. 560-566 , 2020
Link: https://doi.org/10.1021/..
 
?
6

Discovery of Trifluoromethyl Glycol Carbamates as Potent an..:

McAllister, Laura A. ; Butler, Christopher R. ; Mente, Scot...
Journal of Medicinal Chemistry.  61 (2018)  7 - p. 3008-3026 , 2018
Link: https://doi.org/10.1021/..
 
?
7

[P2–083]: THE EFFECTS OF A NOVEL NON‐CATECHOL DOPAMINE PART..:

Moore, Tara L. ; Smith, Rebecca ; Bowley, Bethany...
Alzheimer's & Dementia.  13 (2017)  7S_Part_13 - p. , 2017
Link: https://doi.org/10.1016/..
 
?
8

Systematic N-methylation of oxytocin: Impact on pharmacolog..:

Sciabola, Simone ; Goetz, Gilles H. ; Bai, Guoyun...
Bioorganic & Medicinal Chemistry.  24 (2016)  16 - p. 3513-3520 , 2016
Link: https://doi.org/10.1016/..
 
?
9

Discovery and Preclinical Characterization of 1-Methyl-3-(4..:

Zhang, Lei ; Balan, Gayatri ; Barreiro, Gabriela...
Journal of Medicinal Chemistry.  57 (2014)  3 - p. 861-877 , 2014
Link: https://doi.org/10.1021/..
 
?
10

Discovery of hydroxamate bioisosteres as KAT II inhibitors ..:

Henderson, Jaclyn L. ; Sawant-Basak, Aarti ; Tuttle, Jamison B....
MedChemComm.  4 (2013)  1 - p. 125-129 , 2013
Link: https://doi.org/10.1039/..
 
?
11

Application of Structure-Based Drug Design and Parallel Che..:

Claffey, Michelle M. ; Helal, Christopher J. ; Verhoest, Patrick R....
Journal of Medicinal Chemistry.  55 (2012)  21 - p. 9055-9068 , 2012
Link: https://doi.org/10.1021/..
 
?
12

Structure-Based Design of Irreversible Human KAT II Inhibit..:

Tuttle, Jamison B. ; Anderson, Marie ; Bechle, Bruce M....
ACS Medicinal Chemistry Letters.  4 (2012)  1 - p. 37-40 , 2012
Link: https://doi.org/10.1021/..
 
?
13

Discovery of Brain-Penetrant, Irreversible Kynurenine Amino..:

Dounay, Amy B. ; Anderson, Marie ; Bechle, Bruce M....
ACS Medicinal Chemistry Letters.  3 (2012)  3 - p. 187-192 , 2012
Link: https://doi.org/10.1021/..
 
?
14

Design and Discovery of 6-[(3S,4S)-4-Methyl-1-(pyrimidin-2-..:

Verhoest, Patrick R. ; Fonseca, Kari R. ; Hou, Xinjun...
Journal of Medicinal Chemistry.  55 (2012)  21 - p. 9045-9054 , 2012
Link: https://doi.org/10.1021/..
 
?
15

Use of Structure-Based Design to Discover a Potent, Selecti..:

Helal, Christopher J. ; Kang, Zhijun ; Hou, Xinjun...
Journal of Medicinal Chemistry.  54 (2011)  13 - p. 4536-4547 , 2011
Link: https://doi.org/10.1021/..
 
1-15